- (1) provide draft rules made under this chapter to the advisory board for the advisory board's review;
(2) consult with the advisory board before issuing an additional:
- (a) cultivation facility license under Section 4-41a-205; or
- (b) pharmacy license under Section 4-41a-1005;
- (3) consult with the advisory board regarding fees set by the department that pertain to the medical cannabis program; and
- (4) when appropriate, consult with the advisory board regarding issues that arise in the medical cannabis program.
Enacted by Chapter 273, 2023 General Session